Searched for
SUN PHARMA LABORATORIES
Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select playersIndia's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceuti...- No love for the middle: CPHI Milan exposes India’s pharma scaling challengeIndian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- ChrysCapital to take minority stake in Linux laboratoriesLinux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- MFs turn selective, pick Coal India, LIC among large-caps in AugustAmid the backdrop of increasing US interest rates in August, fund managers proceeded with caution, prioritizing large-cap stocks that offer...
- Sun Pharma incorporates global treasury arm at IFSC, GIFT CityOn September 8, 2026, Sun Pharmaceutical Industries Ltd announced the establishment of its new subsidiary, Sun Pharma Global Treasury Centr...
- Tata Capital Healthcare Fund to exit Linux Laboratories as ChrysCapital buys 20-25% stakePrivate equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...
- Delhi HC orders forensic audit of Fortis, IHH and RHT transactions in $4.6-billion Daiichi-Singh caseThe Delhi High Court on Monday ordered the appointment of a forensic auditor to examine transactions involving Fortis Healthcare, Malaysia’...
- Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...
- Sun will require HC nod for Semaglutide tablet launchThe Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
- Sun Pharma unit to invest Rs 3,000 cr on new plant in Madhya PradeshSun Pharmaceutical Industries' subsidiary, Sun Pharma Laboratories Ltd, has approved a Rs 3,000 crore investment for a new greenfield formu...
- Delhi HC upholds injunction against Glenmark PharmaSun Pharma Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries, and Glenmark are contesting over their right to use dr...
- Sun Pharma's senior exec, wife settle insider trading case with SebiCurrently, Abhay Gandhi is CEO of Sun Pharma's North America business.
- Sun Pharma lab’s senior exec, wife settle insider trading case with SebiThe case relates to their trading in shares of Ranbaxy Laboratories in 2014.
- Sun Pharma Laboratories to raise Rs 2,800 crore from banks: ICRADespite acquisitions, this year has been tough for Sun as the company has been battling quality issues in its own manufacturing facilities.
- Andhra High Court order not to impact merger with Ranbaxy: Sun PharmaLast week, the court had vacated the status quo order it had issued earlier on the merger process between Sun Pharma and Ranbaxy.
Load More
